Association of BRCA2 N372H polymorphism with cancer susceptibility: A comprehensive review and meta-analysis

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Xue, Wen Qiong ^a   He, Yong Qiao ^a   Zhu, Jin Hong ^b   Ma, Jian Qun ^b   He, Jing ^a   Jia, Wei Hua ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; BRCA2 PROTEIN, HUMAN;

BREAST TUMOR; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; META ANALYSIS; PATHOLOGY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84941963449     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06791     Document Type: Article

References (46)

1. Wood, R. D., Mitchell, M., Sgouros, J. & Lindahl, T. Human DNA repair genes. Science 291, 1284-9 (2001).
2. Christmann, M., Tomicic, M. T., Roos, W. P. & Kaina, B. Mechanisms of human DNA repair: an update. Toxicology 193, 3-34 (2003).
3. Jackson, S. P. Sensing and repairing DNA double-strand breaks. Carcinogenesis 23, 687-96 (2002).
4. Pierce, A. J. et al. Double-strand breaks and tumorigenesis. Trends Cell Biol 11, S52-9 (2001).
5. Lord, C. J. & Ashworth, A. RAD51, BRCA2 and DNA repair: a partial resolution. Nat Struct Mol Biol 14, 461-2 (2007).
6. Davies, O. R. & Pellegrini, L. Interaction with the BRCA2 C terminus protects RAD51-DNA filaments from disassembly by BRC repeats. Nat Struct Mol Biol 14, 475-83 (2007).
7. Esashi, F., Galkin, V. E., Yu, X., Egelman, E. H. & West, S. C. Stabilization of RAD51 nucleoprotein filaments by the C-terminal region of BRCA2. Nat Struct Mol Biol 14, 468-74 (2007).
8. Pellegrini, L. et al. Insights into DNA recombination from the structure of a RAD51-BRCA2 complex. Nature 420, 287-93 (2002).
9. Venkitaraman, A. R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108, 171-82 (2002).
10. Pharoah, P. D. et al. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31, 33-6 (2002).
11. Fuks, F., Milner, J. & Kouzarides, T. BRCA2 associates with acetyltransferase activity when bound to P/CAF. Oncogene 17, 2531-4 (1998).
12. Healey, C. S. et al. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat Genet 26, 362-4 (2000).
13. Millikan, R. C., Player, J. S., Decotret, A. R., Tse, C. K. & Keku, T. Polymorphisms in DNA repair genes, medical exposure to ionizing radiation, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14, 2326-34 (2005).
14. Spurdle, A. B. et al. The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. Cancer Epidemiol Biomarkers Prev 11, 413-6 (2002).
15. Breast Cancer Association Consortium. Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst 98, 1382-96 (2006).
16. Qiu, L. X. et al. BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects. Breast Cancer Res Treat 123, 487-90 (2010).
17. Cox, D. G., Hankinson, S. E. & Hunter, D. J. No association between BRCA2 N372H and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14, 1353-4 (2005).
18. Dombernowsky, S. L. et al. Missense polymorphisms in BRCA1 and BRCA2 and risk of breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev 18, 2339-42 (2009).
19. Freedman, M. L. et al. Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort. Hum Mol Genet 13, 2431-41 (2004).
20. Garcia-Closas, M. et al. Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet 119, 376-88 (2006).
21. Hu, R. et al. [Association of polymorphisms of N372H in BRCA2 gene and 135G/C in RAD51 gene and breast cancers]. Sichuan Da Xue Xue Bao Yi Xue Ban 39, 973-5 (2008).
22. Ishitobi, M. et al. Association of BRCA2 polymorphism at codon 784 (Met/Val) with breast cancer risk and prognosis. Clin Cancer Res 9, 1376-80 (2003).
23. Johnson, N. et al. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. Hum Mol Genet 16, 1051-7 (2007).
24. Li, X. et al. Association study between signal nucleotide plymorphism of BRCA2 and susceptibility to sporadic breast cancer in Han Chinese women from Jiangxi province. Chin J Cancer Prev Treat 18, 489-493 (2011).
25. Menzel, H. J. et al. Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations. Br J Cancer 90, 1989-94 (2004).
26. S, D. E. S. et al. Novel sequence variants and common recurrent polymorphisms of BRCA2 in Sri Lankan breast cancer patients and a family with BRCA1 mutations. Exp Ther Med 2, 1163-1170 (2011).
27. Seymour, I. J. C. S. & Zampiga, V. Disease family history and modification of breast cancer risk in common BRCA2 variants. Oncol Rep 19, 783-786 (2008).
28. Sun, X., Li, Z. & Ma, Y. The relationship between BRCA2 N372H polymorphism and risk factor exposure in sporadic breast cancer. Conference papers of tumor etiology research and comprehensive diagnosis (2009).
29. Auranen, A. et al. BRCA2 Arg372Hispolymorphism and epithelial ovarian cancer risk. Int J Cancer 103, 427-30 (2003).
30. Beesley, J. et al. Association between single-nucleotide polymorphisms in hormonemetabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set. Cancer Epidemiol Biomarkers Prev 16, 2557-65 (2007).
31. Wenham, R.M. et al. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer. Clin Cancer Res 9, 4396-403 (2003).
32. Hill, D. A. et al. Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes. Blood 108, 3161-7 (2006).
33. Salagovic, J., Klimcakova, L., Ilencikova, D. & Kafkova, A. Association of follicular lymphoma risk with BRCA2 N372H polymorphism in Slovak population. Med Oncol 29, 1173-8 (2012).
34. Scott, K. et al. RAG1 and BRCA2 polymorphisms in non-Hodgkin lymphoma. Blood 109, 5522-3 (2007).
35. Shen, M. et al. Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia. Haematologica 92, 1180-5 (2007).
36. Shen, M. et al. Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut. Hum Genet 119, 659-68 (2006).
37. Rudd, M. F., Sellick, G. S., Webb, E. L., Catovsky, D. & Houlston, R. S. Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. Blood 108, 638-44 (2006).
38. Agalliu, I. et al. Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes Control 21, 289-300 (2010).
39. Hu, N. et al. Common genetic variants of TP53 and BRCA2 in esophageal cancer patients and healthy individuals from low and high risk areas of northern China. Cancer Detect Prev 27, 132-8 (2003).
40. Wu, X. et al. Bladder cancer predisposition: amultigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet 78, 464-79 (2006).
41. Debniak, T. et al. Common variants of DNA repair genes and malignant melanoma. Eur J Cancer 44, 110-4 (2008).
42. Kotnis, A. et al. Multiple pathway-based genetic variations associated with tobacco related multiple primary neoplasms. PLoS One 7, e30013 (2012).
43. Goode, E. L., Ulrich, C. M. & Potter, J. D. Polymorphisms in DNArepair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11, 1513-30 (2002).
44. Shen, M. et al. Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia. Haematologica 92, 1180-1185 (2007).
45. Liberati, A. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339, b2700 (2009).
46. He, J. et al. Association of MTHFR C677T and A1298C polymorphisms with non-Hodgkin lymphoma susceptibility: Evidence from ameta-analysis. Sci Rep 4, 6159 (2014).